{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:20:59Z","timestamp":1793366459138,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cancer Research for Personalized Medicine"},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agence Nationale pour la Recherche","award":["ANR-18-CE14-0008-01"],"award-info":[{"award-number":["ANR-18-CE14-0008-01"]}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU201903007854"],"award-info":[{"award-number":["EQU201903007854"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Reference Network on Rare Endocrine Conditions","award":["739572"],"award-info":[{"award-number":["739572"]}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103"],"award-info":[{"award-number":["2012_A103"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2015_A228"],"award-info":[{"award-number":["2015_A228"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsche Forschuungsgemeinschaft","award":["314061271-TRR 205"],"award-info":[{"award-number":["314061271-TRR 205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) is a rare cause of Cushing\u2019s syndrome due to bilateral adrenocortical macronodules. Germline inactivating variants of the tumor suppressor gene <jats:italic>ARMC5<\/jats:italic> are responsible for 20\u201325% of apparently sporadic PBMAH cases and 80% of familial presentations. <jats:italic>ARMC5<\/jats:italic> screening is now routinely performed for PBMAH patients and families. Based on literature review and own observation, this study aims to give an overview of both published and unpublished <jats:italic>ARMC5<\/jats:italic> genetic alterations and to compile the available evidence to discriminate pathogenic from benign variants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>146 different germline variants (110 previously published and 36 novel) are identified, including 46% missense substitutions, 45% truncating variants, 3% affecting splice sites, 4% in-frame variants and 2% large deletions. In addition to the germline events, somatic 16p loss-of-heterozygosity and 104 different somatic events are described. The pathogenicity of <jats:italic>ARMC5<\/jats:italic> variants is established on the basis of their frequency in the general population, in silico predictions, familial segregation and tumor DNA sequencing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first extensive review of <jats:italic>ARMC5<\/jats:italic> pathogenic variants. It shows that they are spread on the whole coding sequence. This is a valuable resource for genetic investigations of PBMAH and will help the interpretation of new missense substitutions that are continuously identified.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03554-1","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:46:25Z","timestamp":1738752385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update"],"prefix":"10.1186","volume":"20","author":[{"given":"Lucas","family":"Bouys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vaczlavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora P.","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Violon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jouinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vaduva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Perlemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Dischinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albain","family":"Chansavang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ragazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3008","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the COMETE and ENSAT Networks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"4","key":"3554_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","volume":"44","author":"J Bertherat","year":"2023","unstructured":"Bertherat J, Bourdeau I, Bouys L, Chasseloup F, Kamenick\u00fd P, Lacroix A. Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia. Endocr Rev. 2023;44(4):567\u2013628.","journal-title":"Endocr Rev"},{"issue":"7","key":"3554_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/archsurg.1996.01430190021006","volume":"131","author":"JR Burgess","year":"1996","unstructured":"Burgess JR, Harle RA, Tucker P, Parameswaran V, Davies P, Greenaway TM, et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg. 1996;131(7):699\u2013702.","journal-title":"Arch Surg"},{"issue":"2","key":"3554_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-11-0679","volume":"166","author":"B Gatta-Cherifi","year":"2012","unstructured":"Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V, et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database. Eur J Endocrinol. 2012;166(2):269\u201379.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"3554_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12902-022-01022-6","volume":"22","author":"V Chavoshi","year":"2022","unstructured":"Chavoshi V, Tamehri Zadeh SS, Khalili S, Rabbani A, Matini SAH, Mohsenifar Z, et al. Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review. BMC Endocr Disord. 2022;22(1):108.","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"3554_CR5","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/jc.2009-0516","volume":"94","author":"HP Hsiao","year":"2009","unstructured":"Hsiao HP, Kirschner LS, Bourdeau I, Keil MF, Boikos SA, Verma S, et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab. 2009;94(8):2930\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3554_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2169\/internalmedicine.36.536","volume":"36","author":"N Yamakita","year":"1997","unstructured":"Yamakita N, Murai T, Ito Y, Miura K, Ikeda T, Miyamoto K, et al. Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene. Intern Med. 1997;36(8):536\u201342.","journal-title":"Intern Med"},{"issue":"21","key":"3554_CR7","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","volume":"16","author":"S Gaujoux","year":"2010","unstructured":"Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, et al. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res. 2010;16(21):5133\u201341.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3554_CR8","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1210\/jc.2004-2377","volume":"90","author":"L Matyakhina","year":"2005","unstructured":"Matyakhina L, Freedman RJ, Bourdeau I, Wei MH, Stergiopoulos SG, Chidakel A, et al. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab. 2005;90(6):3773\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3554_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","volume":"189","author":"B Shuch","year":"2013","unstructured":"Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, et al. Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol. 2013;189(2):430\u20135.","journal-title":"J Urol"},{"issue":"5","key":"3554_CR10","doi-asserted-by":"publisher","first-page":"bvac041","DOI":"10.1210\/jendso\/bvac041","volume":"6","author":"HLS Charchar","year":"2022","unstructured":"Charchar HLS, Fragoso MCBV. An overview of the heterogeneous causes of cushing syndrome resulting from primary macronodular adrenal hyperplasia (PMAH). J Endocr Soc. 2022;6(5):bvac041.","journal-title":"J Endocr Soc."},{"issue":"1","key":"3554_CR11","first-page":"189","volume":"76","author":"JC Findlay","year":"1993","unstructured":"Findlay JC, Sheeler LR, Engeland WC, Aron DC. Familial adrenocorticotropin-independent Cushing\u2019s syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 1993;76(1):189\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"3554_CR12","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assi\u00e9","year":"2013","unstructured":"Assi\u00e9 G, Lib\u00e9 R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W, et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N Engl J Med. 2013;369(22):2105\u201314.","journal-title":"N Engl J Med"},{"issue":"6","key":"3554_CR13","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/jc.2014-4204","volume":"100","author":"S Espiard","year":"2015","unstructured":"Espiard S, Drougat L, Lib\u00e9 R, Assi\u00e9 G, Perlemoine K, Guignat L, et al. ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab. 2015;100(6):E926-935.","journal-title":"J Clin Endocrinol Metab"},{"key":"3554_CR14","doi-asserted-by":"crossref","unstructured":"Cavalcante IP, Nishi M, Zerbini MCN, Almeida MQ, Brondani VB, Botelho MLA de A, et al. The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH). Mol Cell Endocrinol. 2018;460:36\u201346.","DOI":"10.1016\/j.mce.2017.06.027"},{"issue":"4","key":"3554_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/ERC-19-0502","volume":"27","author":"IP Cavalcante","year":"2020","unstructured":"Cavalcante IP, Vaczlavik A, Drougat L, Lotfi CFP, Perlemoine K, Ribes C, et al. Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation. Endocr Relat Cancer. 2020;27(4):221\u201330.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"3554_CR16","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1111\/jcmm.16306","volume":"25","author":"G Yan","year":"2021","unstructured":"Yan G, Liu N, Tian J, Fu Y, Wei W, Zou J, et al. Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation. J Cell Mol Med. 2021;25(6):3149\u201359.","journal-title":"J Cell Mol Med"},{"issue":"18","key":"3554_CR17","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","volume":"26","author":"A Berthon","year":"2017","unstructured":"Berthon A, Faucz FR, Espiard S, Drougat L, Bertherat J, Stratakis CA. Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function. Hum Mol Genet. 2017;26(18):3495\u2013507.","journal-title":"Hum Mol Genet"},{"key":"3554_CR18","doi-asserted-by":"publisher","first-page":"13834","DOI":"10.1038\/ncomms13834","volume":"8","author":"Y Hu","year":"2017","unstructured":"Hu Y, Lao L, Mao J, Jin W, Luo H, Charpentier T, et al. Armc5 deletion causes developmental defects and compromises T-cell immune responses. Nat Commun. 2017;8:13834.","journal-title":"Nat Commun"},{"issue":"3","key":"3554_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12020-021-02645-w","volume":"71","author":"L Bouys","year":"2021","unstructured":"Bouys L, Chiodini I, Arlt W, Reincke M, Bertherat J. Update on primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrine. 2021;71(3):595\u2013603.","journal-title":"Endocrine"},{"issue":"1","key":"3554_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/EJE-21-1032","volume":"187","author":"L Bouys","year":"2022","unstructured":"Bouys L, Vaczlavik A, Jouinot A, Vaduva P, Espiard S, Assi\u00e9 G, et al. Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients. Eur J Endocrinol. 2022;187(1):123\u201334.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"3554_CR21","doi-asserted-by":"publisher","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","volume":"99","author":"L Gagliardi","year":"2014","unstructured":"Gagliardi L, Schreiber AW, Hahn CN, Feng J, Cranston T, Boon H, et al. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2014;99(9):E1784-1792.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3554_CR22","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1210\/jc.2014-2648","volume":"100","author":"U Elbelt","year":"2015","unstructured":"Elbelt U, Trovato A, Kloth M, Gentz E, Finke R, Spranger J, et al. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. J Clin Endocrinol Metab. 2015;100(1):E119-128.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3554_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/EJE-15-0642","volume":"174","author":"I Bourdeau","year":"2016","unstructured":"Bourdeau I, Oble S, Magne F, L\u00e9vesque I, C\u00e1ceres-Gorriti KY, Nolet S, et al. ARMC5 mutations in a large French-Canadian family with cortisol-secreting \u03b2-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia. Eur J Endocrinol. 2016;174(1):85\u201396.","journal-title":"Eur J Endocrinol"},{"key":"3554_CR24","doi-asserted-by":"crossref","unstructured":"Alencar GA, Lerario AM, Nishi MY, Mariani BM de P, Almeida MQ, Tremblay J, et al. ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J Clin Endocrinol Metab. 2014;99(8):E1501\u20131509.","DOI":"10.1210\/jc.2013-4237"},{"key":"3554_CR25","first-page":"8848151","volume":"2020","author":"MJ Ferreira","year":"2020","unstructured":"Ferreira MJ, Pedro J, Salazar D, Costa C, Arag\u00e3o Rodrigues J, Costa MM, et al. ARMC5 primary bilateral macronodular adrenal hyperplasia associated with a meningioma: a family report. Case Rep Endocrinol. 2020;2020:8848151.","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"3554_CR26","doi-asserted-by":"publisher","first-page":"K7","DOI":"10.1530\/EJE-20-0014","volume":"183","author":"T Jojima","year":"2020","unstructured":"Jojima T, Kogai T, Iijima T, Kato K, Sagara M, Kezuka A, et al. Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report. Eur J Endocrinol. 2020;183(6):K7-12.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"3554_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-024-04680-9","volume":"168","author":"AAM Salame","year":"2024","unstructured":"Salame AAM, Charchar HLS, de Oliveira Dourado JP, Mendonca B, Alencar GA, de Ara\u00fajo LJT, et al. Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5- a case series. J Neurooncol. 2024;168(3):405\u201313.","journal-title":"J Neurooncol"},{"issue":"12","key":"3554_CR28","doi-asserted-by":"publisher","first-page":"e4531","DOI":"10.1210\/clinem\/dgaa631","volume":"105","author":"SS Damjanovic","year":"2020","unstructured":"Damjanovic SS, Antic JA, Elezovic-Kovacevic VI, Dundjerovic DM, Milicevic IT, Beleslin-Cokic BB, et al. ARMC5 alterations in patients with sporadic neuroendocrine tumors and multiple endocrine neoplasia Type 1 (MEN1). J Clin Endocrinol Metab. 2020;105(12):e4531-4542.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3554_CR29","doi-asserted-by":"publisher","first-page":"E900","DOI":"10.1210\/jc.2014-4167","volume":"100","author":"M Zilbermint","year":"2015","unstructured":"Zilbermint M, Xekouki P, Faucz FR, Berthon A, Gkourogianni A, Schernthaner-Reiter MH, et al. Primary aldosteronism and ARMC5 variants. J Clin Endocrinol Metab. 2015;100(6):E900-909.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3554_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/jhh.2015.98","volume":"30","author":"P Mulatero","year":"2016","unstructured":"Mulatero P, Schiavi F, Williams TA, Monticone S, Barbon G, Opocher G, et al. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. J Hum Hypertens. 2016;30(6):374\u20138.","journal-title":"J Hum Hypertens"},{"issue":"12","key":"3554_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/jhh.2017.71","volume":"31","author":"SMC De Sousa","year":"2017","unstructured":"De Sousa SMC, Stowasser M, Feng J, Schreiber AW, Wang P, Hahn CN, et al. ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). J Hum Hypertens. 2017;31(12):857\u20139.","journal-title":"J Hum Hypertens"},{"key":"3554_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114088","volume":"205","author":"M Scatolini","year":"2024","unstructured":"Scatolini M, Grisanti S, Tomaiuolo P, Grosso E, Basile V, Cosentini D, et al. Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. Eur J Cancer. 2024;205: 114088.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3554_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"3554_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/ejendo\/lvad088","volume":"189","author":"V Morelli","year":"2023","unstructured":"Morelli V, Elli FM, Frigerio S, Vena W, Palmieri S, Lucca C, et al. Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas. Eur J Endocrinol. 2023;189(2):242\u201351.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"3554_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.4158\/EP15756.OR","volume":"21","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Tatsuno I, Oohara E, Nakayama A, Komai E, Shiga A, et al. Germline deletion of armc5 in familial primary macronodular adrenal hyperplasia. Endocr Pract. 2015;21(10):1152\u201360.","journal-title":"Endocr Pract"},{"key":"3554_CR36","first-page":"16","volume":"2017","author":"T Rego","year":"2017","unstructured":"Rego T, Fonseca F, Espiard S, Perlemoine K, Bertherat J, Agapito A. ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrinol Diabetes Metab Case Rep. 2017;2017:16\u20130135.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"3554_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12020-016-0956-z","volume":"55","author":"NM Albiger","year":"2017","unstructured":"Albiger NM, Regazzo D, Rubin B, Ferrara AM, Rizzati S, Taschin E, et al. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype. Endocrine. 2017;55(3):959\u201368.","journal-title":"Endocrine"},{"issue":"1","key":"3554_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191602","volume":"13","author":"L Yu","year":"2018","unstructured":"Yu L, Zhang J, Guo X, Chen X, He Z, He Q. ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia. PLoS ONE. 2018;13(1): e0191602.","journal-title":"PLoS ONE"},{"issue":"7","key":"3554_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/ERC-20-0102","volume":"27","author":"F Hannah-Shmouni","year":"2020","unstructured":"Hannah-Shmouni F, Berthon A, Faucz FR, Briceno JM, Maria AG, Demidowich A, et al. Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia. Endocr Relat Cancer. 2020;27(7):403\u201313.","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"3554_CR40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/js.2019-00210","volume":"3","author":"C Kyo","year":"2019","unstructured":"Kyo C, Usui T, Kosugi R, Torii M, Yonemoto T, Ogawa T, et al. ARMC5 alterations in primary macronodular adrenal hyperplasia (PMAH) and the clinical state of variant carriers. J Endocr Soc. 2019;3(10):1837\u201346.","journal-title":"J Endocr Soc"},{"key":"3554_CR41","doi-asserted-by":"crossref","unstructured":"Wurth R, Kamilaris C, Nilubol N, Sadowski SM, Berthon A, Quezado MM, et al. Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia. Endocrinol Diabetes Metab Case Rep. 2020;2020:20-0006, EDM200006.","DOI":"10.1530\/EDM-20-0006"},{"issue":"12","key":"3554_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1507\/endocrj.EJ20-0163","volume":"67","author":"F Zhang","year":"2020","unstructured":"Zhang F, Lin X, Yu X. Primary macronodular adrenal hyperplasia (PMAH) can be generated by a new ARMC5 germline variant (c.52C>T (p.Gln18X)). Endocr J. 2020;67(12):1179\u201386.","journal-title":"Endocr J"},{"issue":"3","key":"3554_CR43","first-page":"119","volume":"71","author":"A Pi\u00f1ar-Guti\u00e9rrez","year":"2024","unstructured":"Pi\u00f1ar-Guti\u00e9rrez A, Mangas-Cruz M\u00c1, de Lara-Rodr\u00edguez I, Rem\u00f3n-Ruiz P, Del Can-S\u00e1nchez D, Tous Castillo M, et al. Familial bilateral macronodular adrenal hyperplasia due to a novel ARMC 5 germline mutation: clinical status and possible association with other neoplasms. Endocrinol Diabetes Nutr (Engl Ed). 2024;71(3):119\u201323.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"3554_CR44","doi-asserted-by":"crossref","unstructured":"Mariani BM de P, Nishi MY, Wanichi IQ, Brondani VB, Lacombe AMF, Charchar H, et al. Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing\u2019s Syndrome Associated With Bilateral Adrenal Nodules. Front Endocrinol (Lausanne). 2020;11:36.","DOI":"10.3389\/fendo.2020.00036"},{"issue":"4","key":"3554_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1530\/EJE-15-0205","volume":"173","author":"R Correa","year":"2015","unstructured":"Correa R, Zilbermint M, Berthon A, Espiard S, Batsis M, Papadakis GZ, et al. The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur J Endocrinol. 2015;173(4):435\u201340.","journal-title":"Eur J Endocrinol"},{"key":"3554_CR46","doi-asserted-by":"crossref","unstructured":"Violon F, Bouys L, Vaduva P, Chansavang A, Vaquier L, Letourneur F, et al. Somatic molecular heterogeneity in bilateral macronodular adrenocortical disease (BMAD) differs among the pathological subgroups. Endocr Pathol. 2024","DOI":"10.1530\/endoabs.90.RC5.3"},{"issue":"6","key":"3554_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","volume":"63","author":"S Lee","year":"2005","unstructured":"Lee S, Hwang R, Lee J, Rhee Y, Kim DJ, Chung UI, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf). 2005;63(6):625\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3554_CR48","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","volume":"99","author":"FR Faucz","year":"2014","unstructured":"Faucz FR, Zilbermint M, Lodish MB, Szarek E, Trivellin G, Sinaii N, et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J Clin Endocrinol Metab. 2014;99(6):E1113-1119.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"3554_CR49","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMe1312792","volume":"369","author":"A Lacroix","year":"2013","unstructured":"Lacroix A. Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;369(22):2147\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"3554_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","volume":"24","author":"A Vaczlavik","year":"2022","unstructured":"Vaczlavik A, Bouys L, Violon F, Giannone G, Jouinot A, Armignacco R, et al. KDM1A inactivation causes hereditary food-dependent Cushing syndrome. Genet Med. 2022;24(2):374\u201383.","journal-title":"Genet Med"},{"issue":"12","key":"3554_CR51","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","volume":"9","author":"F Chasseloup","year":"2021","unstructured":"Chasseloup F, Bourdeau I, Tabarin A, Regazzo D, Dumontet C, Ladurelle N, et al. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing\u2019s syndrome: a multicentre, retrospective, cohort study. Lancet Diabetes Endocrinol. 2021;9(12):813\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"3554_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","volume":"18","author":"IP Cavalcante","year":"2022","unstructured":"Cavalcante IP, Berthon A, Fragoso MC, Reincke M, Stratakis CA, Ragazzon B, et al. Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease. Nat Rev Endocrinol. 2022;18(11):699\u2013711.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"3554_CR53","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1093\/ejendo\/lvad026","volume":"188","author":"A Lacroix","year":"2023","unstructured":"Lacroix A. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing\u2019s syndrome. Eur J Endocrinol. 2023;188(3):R56-72.","journal-title":"Eur J Endocrinol"},{"key":"3554_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/a-2359-8051","volume":"132","author":"L Bouys","year":"2024","unstructured":"Bouys L, Bertherat J. From the first case reports to KDM1A identification: 35 years of food (GIP)-dependent Cushing\u2019s syndrome. Exp Clin Endocrinol Diabetes. 2024;132:697.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3554_CR55","doi-asserted-by":"crossref","unstructured":"Bouys L, Violon F, Louiset E, Sibony M, Lefebvre H, Bertherat J. Bilateral Adrenocortical Nodular Disease and Cushing\u2019s Syndrome. J Clin Endocrinol Metab. 2024;dgae419.","DOI":"10.1210\/clinem\/dgae419"},{"issue":"14","key":"3554_CR56","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM199210013271403","volume":"327","author":"Y Reznik","year":"1992","unstructured":"Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, et al. Food-dependent Cushing\u2019s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327(14):981\u20136.","journal-title":"N Engl J Med"},{"issue":"14","key":"3554_CR57","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199210013271402","volume":"327","author":"A Lacroix","year":"1992","unstructured":"Lacroix A, Bolt\u00e9 E, Tremblay J, Dupr\u00e9 J, Poitras P, Fournier H, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion\u2014A new cause of Cushing\u2019s syndrome. N Engl J Med. 1992;327(14):974\u201380.","journal-title":"N Engl J Med"},{"issue":"21","key":"3554_CR58","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","volume":"341","author":"A Lacroix","year":"1999","unstructured":"Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone\u2014dependent Cushing\u2019s syndrome. N Engl J Med. 1999;341(21):1577\u201381.","journal-title":"N Engl J Med"},{"issue":"20","key":"3554_CR59","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM199711133372004","volume":"337","author":"A Lacroix","year":"1997","unstructured":"Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing\u2019s syndrome. N Engl J Med. 1997;337(20):1429\u201334.","journal-title":"N Engl J Med"},{"issue":"8","key":"3554_CR60","first-page":"2414","volume":"82","author":"A Lacroix","year":"1997","unstructured":"Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing\u2019s syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 1997;82(8):2414\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3554_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1210\/jc.2002-021107","volume":"88","author":"D Cartier","year":"2003","unstructured":"Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2003;88(1):248\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3554_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12022-023-09751-7","volume":"34","author":"F Violon","year":"2023","unstructured":"Violon F, Bouys L, Berthon A, Ragazzon B, Barat M, Perlemoine K, et al. Impact of morphology in the genotype and phenotype correlation of bilateral macronodular adrenocortical disease (BMAD): a series of clinicopathologically well-characterized 35 cases. Endocr Pathol. 2023;34(2):179\u201399.","journal-title":"Endocr Pathol"},{"key":"3554_CR63","doi-asserted-by":"crossref","unstructured":"Vaduva P, Bonnet F, Bertherat J. Molecular basis of primary aldosteronism and adrenal cushing syndrome. J Endocr Soc. 2020;4(9):bvaa075.","DOI":"10.1210\/jendso\/bvaa075"},{"issue":"11","key":"3554_CR64","first-page":"615","volume":"29","author":"IP Cavalcante","year":"2022","unstructured":"Cavalcante IP, Rizk-Rabin M, Ribes C, Perlemoine K, Hantel C, Berthon A, et al. Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover. Endocr Relat Cancer. 2022;29(11):615\u201324.","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"3554_CR65","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.1093\/nar\/gkac483","volume":"50","author":"L Lao","year":"2022","unstructured":"Lao L, Bourdeau I, Gagliardi L, He X, Shi W, Hao B, et al. ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. Nucleic Acids Res. 2022;50(11):6343\u201367.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"3554_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151390","volume":"7","author":"Y Okuno","year":"2022","unstructured":"Okuno Y, Fukuhara A, Otsuki M, Shimomura I. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors. JCI Insight. 2022;7(16): e151390.","journal-title":"JCI Insight"},{"issue":"1","key":"3554_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13059-023-03147-w","volume":"25","author":"H Luo","year":"2024","unstructured":"Luo H, Lao L, Au KS, Northrup H, He X, Forget D, et al. ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans. Genome Biol. 2024;25(1):19.","journal-title":"Genome Biol"},{"key":"3554_CR68","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1507\/endocrj.EJ24-0177","volume":"71","author":"Y Okuno","year":"2024","unstructured":"Okuno Y, Fukuhara A, Shimomura I. The role of oxidative stress, glucocorticoid receptor and ARMC5 in lipid metabolism. Endocr J. 2024;71:1097.","journal-title":"Endocr J"},{"issue":"7944","key":"3554_CR69","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-022-05420-7","volume":"613","author":"HO Heyne","year":"2023","unstructured":"Heyne HO, Karjalainen J, Karczewski KJ, Lemmel\u00e4 SM, Zhou W, Finn G, et al. Mono- and biallelic variant effects on disease at biobank scale. Nature. 2023;613(7944):519\u201325.","journal-title":"Nature"},{"issue":"1","key":"3554_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40246-022-00407-x","volume":"16","author":"E Masson","year":"2022","unstructured":"Masson E, Zou WB, G\u00e9nin E, Cooper DN, Le Gac G, Fichou Y, et al. Expanding ACMG variant classification guidelines into a general framework. Hum Genomics. 2022;16(1):31.","journal-title":"Hum Genomics"},{"issue":"2","key":"3554_CR71","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2010-1885","volume":"96","author":"S Bonnet","year":"2011","unstructured":"Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B, et al. Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J Clin Endocrinol Metab. 2011;96(2):E419-426.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3554_CR72","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1210\/jc.2008-0631","volume":"93","author":"S Gaujoux","year":"2008","unstructured":"Gaujoux S, Tissier F, Groussin L, Lib\u00e9 R, Ragazzon B, Launay P, et al. Wnt\/beta-catenin and 3\u2019,5\u2019-cyclic adenosine 5\u2019-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab. 2008;93(10):4135\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"3554_CR73","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","volume":"65","author":"F Tissier","year":"2005","unstructured":"Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagner\u00e9 AM, et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005;65(17):7622\u20137.","journal-title":"Cancer Res"},{"issue":"11","key":"3554_CR74","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein F, Fassnacht M, Assi\u00e9 G, Calebiro D, Stratakis CA, Osswald A, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N Engl J Med. 2014;370(11):1019\u201328.","journal-title":"N Engl J Med"},{"issue":"6186","key":"3554_CR75","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1249480","volume":"344","author":"Y Cao","year":"2014","unstructured":"Cao Y, He M, Gao Z, Peng Y, Li Y, Li L, et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome. Science. 2014;344(6186):913\u20137.","journal-title":"Science"},{"issue":"10","key":"3554_CR76","doi-asserted-by":"publisher","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","volume":"99","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi G, Kisker C, Calebiro D, Mannelli M, Canu L, Arnaldi G, et al. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study. J Clin Endocrinol Metab. 2014;99(10):E2093-2100.","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"3554_CR77","first-page":"5308","volume":"63","author":"J Bertherat","year":"2003","unstructured":"Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res. 2003;63(17):5308\u201319.","journal-title":"Cancer Res"},{"issue":"4","key":"3554_CR78","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1507\/endocrj.47.461","volume":"47","author":"H Kobayashi","year":"2000","unstructured":"Kobayashi H, Usui T, Fukata J, Yoshimasa T, Oki Y, Nakao K. Mutation analysis of Gsalpha, adrenocorticotropin receptor and p53 genes in Japanese patients with adrenocortical neoplasms: including a case of Gsalpha mutation. Endocr J. 2000;47(4):461\u20136.","journal-title":"Endocr J"},{"issue":"9","key":"3554_CR79","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/jc.2016-1586","volume":"101","author":"CL Ronchi","year":"2016","unstructured":"Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assi\u00e9 G, Weigand I, et al. Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab. 2016;101(9):3526\u201338.","journal-title":"J Clin Endocrinol Metab"},{"key":"3554_CR80","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","volume":"441","author":"A Berthon","year":"2017","unstructured":"Berthon A, Faucz F, Bertherat J, Stratakis CA. Analysis of ARMC5 expression in human tissues. Mol Cell Endocrinol. 2017;441:140\u20135.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"3554_CR81","doi-asserted-by":"publisher","first-page":"bvaa162","DOI":"10.1210\/jendso\/bvaa162","volume":"5","author":"R Wurth","year":"2021","unstructured":"Wurth R, Tirosh A, Kamilaris CDC, Camacho J, Faucz FR, Maria AG, et al. Volumetric modeling of adrenal gland size in primary bilateral macronodular adrenocortical hyperplasia. J Endocr Soc. 2021;5(1):bvaa162.","journal-title":"J Endocr Soc."},{"issue":"4","key":"3554_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2126","volume":"11","author":"M Giacch\u00e9","year":"2023","unstructured":"Giacch\u00e9 M, Panarotto A, Mori L, Poliani PL, Lanzi R, Lena MS, et al. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH). Mol Genet Genomic Med. 2023;11(4): e2126.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"3554_CR83","volume":"15","author":"N Naser","year":"2023","unstructured":"Naser N, Nava V, Khosla S, Nylen E. Allelic variant of armadillo repeat containing protein 5 (ARMC5) in myelolipoma mimicking pheochromocytoma: a case report. Cureus. 2023;15(1): e34454.","journal-title":"Cureus"},{"issue":"1","key":"3554_CR84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12902-022-01128-x","volume":"22","author":"W Wang","year":"2022","unstructured":"Wang W, Wei F. A novel pathogenic variant of ARMC5 in a patient with primary bilateral macronodular adrenal hyperplasia: a case report. BMC Endocr Disord. 2022;22(1):211.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"3554_CR85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12881-018-0564-2","volume":"19","author":"Q Liu","year":"2018","unstructured":"Liu Q, Tong D, Xu J, Yang X, Yi Y, Zhang D, et al. A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report. BMC Med Genet. 2018;19(1):49.","journal-title":"BMC Med Genet"},{"key":"3554_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.02.011","volume":"191","author":"A Berthon","year":"2019","unstructured":"Berthon A, Hannah-Shmouni F, Maria AG, Faucz FR, Stratakis CA. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia. J Steroid Biochem Mol Biol. 2019;191: 105316.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"3554_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13256-017-1529-3","volume":"12","author":"P Jin","year":"2018","unstructured":"Jin P, Janjua MU, Zhang Q, Dong CS, Yang Y, Mo ZH. Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report. J Med Case Rep. 2018;12(1):13.","journal-title":"J Med Case Rep"},{"issue":"1","key":"3554_CR88","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12920-021-00896-0","volume":"14","author":"WT He","year":"2021","unstructured":"He WT, Wang X, Song W, Song XD, Lu YJ, Lv YK, et al. A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia. BMC Med Genom. 2021;14(1):126.","journal-title":"BMC Med Genom"},{"issue":"3","key":"3554_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1507\/endocrj.EJ17-0317","volume":"65","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Cui L, Gao JP, Yan WH, Jin N, Chen K, et al. Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia. Endocr J. 2018;65(3):269\u201379.","journal-title":"Endocr J"},{"issue":"3","key":"3554_CR90","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12020-016-0988-4","volume":"53","author":"H Emms","year":"2016","unstructured":"Emms H, Tsirou I, Cranston T, Tsagarakis S, Grossman AB. Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia? Endocrine. 2016;53(3):801\u20138.","journal-title":"Endocrine"},{"issue":"32","key":"3554_CR91","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1556\/650.2023.32817","volume":"164","author":"Z Hella","year":"2023","unstructured":"Hella Z, T\u0151ke J, Pat\u00f3cs A, Varga Z, Dabasi G, Kov\u00e1cs GL, et al. Macronodular adrenal hyperplasia causing Cushing\u2019s syndrome due to ARMC5 gene mutation. Orv Hetil. 2023;164(32):1271\u20137.","journal-title":"Orv Hetil"},{"issue":"1","key":"3554_CR92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12902-023-01324-3","volume":"23","author":"P Tang","year":"2023","unstructured":"Tang P, Zhang J, Peng S, Yan X, Wang Y, Wang S, et al. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations. BMC Endocr Disord. 2023;23(1):77.","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"3554_CR93","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/diagnostics12123028","volume":"12","author":"M Eghbali","year":"2022","unstructured":"Eghbali M, Cheraghi S, Samanian S, Rad I, Meghdadi J, Akbari H, et al. A novel ARMC5 germline variant in primary macronodular adrenal hyperplasia using whole-exome sequencing. Diagnostics (Basel). 2022;12(12):3028.","journal-title":"Diagnostics (Basel)"},{"key":"3554_CR94","doi-asserted-by":"crossref","unstructured":"Khosla S, Alsarraf F, Nylen ES. Pituitary macroadenoma with macronodular adrenal hyperplasia and novel armadillo repeat-containing protein 5 (ARMC5) mutation. JCEM Case Rep. 2024;2(2):luad138.","DOI":"10.1210\/jcemcr\/luad138"},{"key":"3554_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.834067","volume":"13","author":"W Vena","year":"2022","unstructured":"Vena W, Morelli V, Carrabba M, Elli F, Fabio G, Muller I, et al. Case report: a novel ARMC5 germline mutation in a patient with primary bilateral macronodular adrenal hyperplasia and hypogammaglobulinemia. Front Genet. 2022;13: 834067.","journal-title":"Front Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03554-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03554-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03554-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:44:02Z","timestamp":1738759442000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03554-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3554"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03554-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients for which a new ARMC5 variant is reported in this work. The study was approved by the local ethic committee of Ile de France I, Paris.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}